An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
Conditions: Systemic Lupus Erythematosus; Systemic Sclerosis; Inflammatory Myopathy; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antiphospholipid Syndrome; Sjogren ' s Syndrome Interventions: Other: YTS109 Sponsors: China Immunotech (Beijing) Biotechnology Co., Ltd.; Shanghai Changzheng Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease
Conditions: Systemic Lupus Erythematosus (SLE); Sjogren ' s Syndrome; Systemic Sclerosis; Inflammatory Myopathy; ANCA Associated Vasculitis; Antiphospholipid Syndrome Interventions: Biological: Anti-CD19-CD3E-CAR-T cells Sponsors: Shanghai Changzheng Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
Conditions: Systemic Lupus Erythematosus; Lupus Nephritis; Autoimmune Diseases; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Granulomatous Polyangiitis; Microscopic Polyangiitis; Systemic Sclerosis; Idiopathic Inflammatory Myopathies; Sjogren ' s Syndrome Interventions: Biological: CD19- BCMA CAR-T cells Sponsors: Essen Biotech Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Intraoperative Application of Fluorescein Sodium Angiography in Vascular Retinopathy
Conditions: Vascular Retinopathy of Left Eye (Disorder); Vascular Retinopathy of Right Eye (Disorder); Diabetic Retinopathy; Retinal Vein Occlusion; Retinal Vasculitis; Vitreous Hemorrhage Interventions: Procedure: Intraoperative Fluorescein Angiography Sponsors: Jie Zhong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis
Conditions: Giant Cell Arteritis Interventions: Drug: AzaFol; Drug: FDG Sponsors: Insel Gruppe AG, University Hospital Bern; Paul Scherrer Institut, Center for Proton Therapy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV
Conditions: Vasculitis Interventions: Drug: Avacopan Sponsors: Amgen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases
Conditions: Systemic Lupus Erythematosus; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Idiopathic Inflammatory Myopathies; Systemic Sclerosis Interventions: Biological: CD19-CAR-DNT cells Sponsors: RenJi Hospital; Guangdong Ruishun Biotech Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)
Conditions: Lupus Erythematosus; Systemic Lupus Erythematosus; SLE (Systemic Lupus); Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Granulomatous Polyangiitis; Microscopic Polyangiitis Interventions: Biological: SC291 Sponsors: Sana Biotechnology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
FKC288 in Participants With Autoimmune Kidney Diseases
Conditions: Lupus Nephritis, ANCA-associated Vasculitis, Membranous Nephropathy, IgG4-related Diseases Interventions: Drug: FKC288 Sponsors: Nanjing University School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells
Conditions: Lupus Nephritis; ANCA Associated Vasculitis Interventions: Drug: PRG-1801 （CAR-T against BCMA） Sponsors: Lingli Dong; Shenzhen Pregene Biopharma Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
How Sirtuin Levels Change During Beh çet Disease
Conditions: Beh çet Disease; Inflammation; Vasculitis Interventions: Diagnostic Test: Take blood samples Sponsors: Karamano ğlu Mehmetbey University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
Clonal Hematopoiesis in Giant Cell Arteritis
Conditions: Giant Cell Arteritis; Temporal Arteritis; Clonal Hematopoiesis of Indeterminate Potential; Horton Disease; Systemic Vasculitis Primary Interventions: Diagnostic Test: Temporal arterial biopsy; Diagnostic Test: Whole exome sequencing; Diagnostic Test: Single cell transcriptomics Sponsors: ASST Fatebenefratelli Sacco Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Study of NM8074 in Patients With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)
Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Interventions: Drug: NM8074; Drug: Placebo Sponsors: NovelMed Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
An Exploratory Study of MT-2990 in Patients With AAV
Conditions: Antineutrophil Cytoplasmic Antibody (ANCA) -Associated Vasculitis (AAV) Interventions: Drug: MT-2990 Sponsors: Mitsubishi Tanabe Pharma Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101
Conditions: Idiopathic Inflammatory Myopathies; Diffuse Cutaneous Systemic Sclerosis; SLE Nephritis; ANCA Associated Vasculitis Interventions: Drug: KYV-101; Drug: Cyclophosphamide; Drug: Fludarabine Sponsors: David Porter; Kyverna Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
